Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma, Basal Cell
|
91 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
cervical cancer
|
268 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Cervix carcinoma
|
283 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Adult Meningioma
|
30 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Meningioma
|
43 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Meningioma, benign, no ICD-O subtype
|
30 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Acute lymphocytic leukemia
|
222 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Adult Hodgkin Lymphoma
|
27 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Childhood Hodgkin Lymphoma
|
29 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Hodgkin Disease
|
148 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Nasopharyngeal carcinoma
|
320 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.030 | 1.000 | 3 | 2006 | 2012 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Colon Carcinoma
|
275 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Leukemia, Myelocytic, Acute
|
6892 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Bladder Neoplasm
|
281 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Cancer of Urinary Tract
|
11 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Carcinoma of bladder
|
309 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Cancer of Digestive System
|
15 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2011 | 2015 | ||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Malignant neoplasm of stomach
|
615 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 |